Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News MSD appoints global human health president

MSD appoints global human health president

30th July 2007

Merck, Sharp and Dohme (MSD) has announced the appointment of Kenneth C Frazier to the position of executive vice president and president of global human health at the firm.

Mr Frazier, who is currently executive vice president and general counsel at MSD, will assume his new role at the start of August 2007.

His new responsibilities will involve overseeing the marketing and sales organisations of the firm across the world, including its vaccine franchises and global pharmaceuticals operations, with Mr Frazier supervising the work of over 30,000 employees.

Richard T Clark, chairman, president and chief executive officer of MSD, said: “In Ken, we are fortunate to have an exceptional leader who knows the company, its business and the industry intimately and who has a demonstrated ability to drive the transformation necessary to achieve our long-term objectives.”

In his new role, Mr Frazier will work with his successor as general counsel, Bruce N Kuhlik, with the men cooperating on ongoing issues related to the firm’s now-withdrawn Vioxx product.

Earlier this month, MSD announced that Peter Kellogg, a Biogen Idec employee, would join the company in August, replacing Judy C Lewent as executive vice president of finance and chief financial officer.

We currently have 9 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.